[HTML][HTML] Severity of Omicron (B. 1.1. 529) and Delta (B. 1.617. 2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United …

…, F Bayley, G Ruffino, G Valentine, G Tilzey… - The Lancet Regional …, 2023 - thelancet.com
g These authors contributed equally, and should be … g These authors contributed equally,
and should be considered … g These authors contributed equally, and should be considered co-…

[HTML][HTML] Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006‒2022

…, Z Amin-Chowdhury, C Grimes, G Ruffino… - Emerging Infectious …, 2023 - ncbi.nlm.nih.gov
Ongoing surveillance after pneumococcal conjugate vaccination (PCV) deployment is
essential to inform policy decisions and monitor serotype replacement. We report serotype and …

[HTML][HTML] Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative …

…, A Tuner, Z Friedrich, L Morrison, G Ruffino… - The Lancet Infectious …, 2021 - thelancet.com
Background On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for
UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine …

[HTML][HTML] Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B. 1.617. 2) and …

…, F Bayley, G Ruffino, G Valentine, G Tilzey… - The Lancet Regional …, 2023 - thelancet.com
Background Whilst other studies have reported the effectiveness of mRNA vaccination against
hospitalisation, including emergency department or intensive care admission, few have …

Assessing the effectiveness of BNT162b2 and ChAdOx1nCoV-19 COVID-19 vaccination in prevention of hospitalisations in elderly and frail adults: a single centre test …

…, R Heath, A Turner, Z Friedrich, L Morrison, G Ruffino… - 2021 - papers.ssrn.com
Background: On 8 th December 2020, deployment of the first vaccine against SARS-CoV-2
authorised for UK use, the mRNA-based vaccine BNT162b2, began, followed by the …

[HTML][HTML] Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study

…, F Bayley, G Ruffino, G Valentine, G Tilzey… - The Lancet Regional …, 2022 - thelancet.com
… Panels D and G indicate differences in these key indicators between SARS-CoV-2 PCR
positive and negative patients for D) age, and G) CCI score, in tabular form. P-values are the …

Blood group type A secretors are associated with a higher risk of COVID‐19 cardiovascular disease complications

…, S Kupzig, L Nichols, C Asby, J Pooley, G Ruffino… - …, 2021 - Wiley Online Library
The SARS‐CoV‐2 virus causes COVID‐19, an infection capable of causing severe disease
and death but which can also be asymptomatic or oligosymptomatic. We investigated …

[HTML][HTML] Protocols for point-of-care-ultrasound (POCUS) in a patient with sepsis; an algorithmic approach

…, J Turpie, I Farhad, G Ruffino - Bulletin of Emergency & …, 2019 - ncbi.nlm.nih.gov
Discussion Sepsis is a medical emergency that requires multidisciplinary team input for better
outcomes. Sepsis definition and management has been evolving and the latest guidelines …

Sicily

G Ruffino - The dialects of Italy, 2006 - taylorfrancis.com
… The basis of these dialects is certainly Aeolian, and their affinity can be ascribed to
migrations in the late eighteenth century which brought the Aeolians first to Ustica (see …

Recent advances in optical methods for thermal expansion measurements

G Ruffino - International Journal of Thermophysics, 1989 - Springer
Progress in optical instrumentation for thermal expansion in the 1980s is reported. These
instruments present some common features: (1) they are designed to operate at high …